Inventor · disambiguated record
Avigdor Levanon
Also filed as: LEVANON AVIGDOR
27 granted patents·10 pending applications·305 citations·filing 1985–2008
97Inventor score
Files withBIO TECHNOLOGY GENERAL CORP25SAVIENT PHARMACEUTICALS INC2BIO TECHNOLOGY GENERAL ISRAEL1HAGAY YOCHEVED1PLAKSIN DANIEL1
Top patents by PatentIndex Score
37 records- 0187US5965383AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Oct 12, 1999·64 cites·21 claims
- 0287US4871835AAnalogs of hGH having antagonistic activity, and uses thereofBIO TECHNOLOGY GENERAL CORP·Filed 1985·Granted Oct 3, 1989·29 cites·3 claims
- 0381US4997916AMethod for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cellBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Mar 5, 1991·16 cites·20 claims
- 0478US7087722B1Fibrin binding domain polypeptides and uses and methods of producing sameSAVIENT PHARMACEUTICALS INC·Filed 2000·Granted Aug 8, 2006·5 cites·4 claims
- 0577US6121426AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Sep 19, 2000·37 cites·8 claims
- 0676US4831120AMethod for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cellBIO TECHNOLOGY GENERAL CORP·Filed 1985·Granted May 16, 1989·14 cites·11 claims
- 0773US6211341B1Polypeptide having factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1999·Granted Apr 3, 2001·26 cites·14 claims
- 0862US5270030AFibrin binding domain polypeptide and method of producingBIO TECHNOLOGY GENERAL CORP·Filed 1990·Granted Dec 14, 1993·19 cites·15 claims
- 0961US5783421ADNA encoding novel polypeptide having Factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jul 21, 1998·8 cites·22 claims
- 1059US7132510B2Specific human antibodies for selective cancer therapyBIO TECHNOLOGY GENERAL ISRAEL·Filed 2001·Granted Nov 7, 2006·2 cites·12 claims
- 1154US5637495APlasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Jun 10, 1997·11 cites·4 claims
- 1251US5679320AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Oct 21, 1997·14 cites·13 claims
- 1350US5670371ABacterial expression of superoxide dismutaseBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Sep 23, 1997·6 cites·2 claims
- 1448US5455158AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1993·Granted Oct 3, 1995·9 cites·8 claims
- 1547US5256546ABacterial expression of porcine growth hormoneBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Oct 26, 1993·13 cites·12 claims
- 1647US2005069955A1Antibodies and uses thereofFiled 2004·Application pending·0 cites
- 1745US2009220486A1Antibodies and uses thereofPLAKSIN DANIEL·Filed 2008·Application pending·0 cites
- 1845US2005152906A1Specific human antibodiesFiled 2004·Application pending·0 cites
- 1944US6054291AExpression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Apr 25, 2000·4 cites·5 claims
- 2044US5858970APolypeptide having Factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Jan 12, 1999·2 cites·9 claims
- 2144US2004208877A1Antibodies and uses thereofFiled 2003·Application pending·0 cites
- 2243US5126252AExpressions vectors containing Lambda PL promoter and T1 T2 RNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and relatedmethodsBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Jun 30, 1992·4 cites·9 claims
- 2343US2004202665A1Compositions and methods for therapeutic treatmentFiled 2003·Application pending·0 cites
- 2441US2005266009A1Antibodies and uses thereofSAVIENT PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2540US2004001839A1Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
- 2640US2007149768A1Specific human antibodies for selective cancer therapyHAGAY YOCHEVED·Filed 2006·Application pending·0 cites
- 2739US2004002450A1Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
- 2839US2004001822A1Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
- 2937US5801017AProduction of recombinant factor Xa inhibitor of leech Hirudo medicinalisBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Sep 1, 1998·4 cites·27 claims
- 3037US5198361APlasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1991·Granted Mar 30, 1993·5 cites·3 claims
- 3136US5869616AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Feb 9, 1999·3 cites·18 claims
- 3236US5863534APolypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jan 26, 1999·3 cites·18 claims
- 3336US5759816AExpression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jun 2, 1998·2 cites·3 claims
- 3436US5112744APlasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutaseBIO TECHNOLOGY GENERAL CORP·Filed 1990·Granted May 12, 1992·3 cites·4 claims
- 3531US5527691AExpression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Jun 18, 1996·1 cites·13 claims
- 3629US5151364AExpression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmidsBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Sep 29, 1992·1 cites·14 claims
- 3727US5081020AExpression vectors containing λPL promoter, T1 T2 rRNA termination sequence and origin of replication derived from a constitutive high copy number plasmid hosts and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1988·Granted Jan 14, 1992·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Avigdor Levanon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →